"10.1371_journal.pone.0025398","plos one","2011-09-30T00:00:00Z","Pierre van Damme; Froukje Kafeja; Alessandra Anemona; Venere Basile; Anne Katrin Hilbert; Ilse De Coster; Simona Rondini; Francesca Micoli; Rana M Qasim Khan; Elisa Marchetti; Vito Di Cioccio; Allan Saul; Laura B Martin; Audino Podda","Center for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium; Novartis Vaccines Institute for Global Health, Siena, Italy; Novartis Vaccines & Diagnostics, Clinical Serology Laboratories, Marburg, Germany","Conceived and designed the experiments: PvD AP AA. Performed the experiments: PvD FK IDC AP AA EM VB RMQK. Analyzed the data: AA. Wrote the paper: PvD AP AA VB AS LBM AKH. Development of the vaccine and production and release of the clinical lot: FM SR VDC LBM AS.","AA, VB, AKH, SR, FM, RMQK, EM, VDC, AS, LBM, AP are all Novartis employees. AS and AP receive stock options from Novartis. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. PvD, FK and IDC are all employees of Univeristy of Antwerp, Belgium.","2011","09","Pierre van Damme","PVD",14,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
